Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Consolidated Net Income: 2012-2025

Historic Consolidated Net Income for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $19.1 million.

  • Veracyte's Consolidated Net Income rose 26.33% to $19.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year increase of 426.92%. This contributed to the annual value of $24.1 million for FY2024, which is 132.44% up from last year.
  • Per Veracyte's latest filing, its Consolidated Net Income stood at $19.1 million for Q3 2025, which was up 2,052.76% from -$980,000 recorded in Q2 2025.
  • Veracyte's 5-year Consolidated Net Income high stood at $19.1 million for Q3 2025, and its period low was -$41.9 million during Q1 2021.
  • Moreover, its 3-year median value for Consolidated Net Income was -$980,000 (2025), whereas its average is -$2.3 million.
  • As far as peak fluctuations go, Veracyte's Consolidated Net Income slumped by 630.33% in 2023, and later soared by 477.04% in 2025.
  • Over the past 5 years, Veracyte's Consolidated Net Income (Quarterly) stood at -$10.5 million in 2021, then soared by 63.16% to -$3.9 million in 2022, then slumped by 630.33% to -$28.3 million in 2023, then skyrocketed by 118.16% to $5.1 million in 2024, then increased by 26.33% to $19.1 million in 2025.
  • Its Consolidated Net Income stands at $19.1 million for Q3 2025, versus -$980,000 for Q2 2025 and $7.0 million for Q1 2025.